The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ligand Pharmaceuticals, Inc shares valued at $244,850 were sold by Espinoza Octavio on Dec 23 ’24. At $116.37 per share, Espinoza Octavio sold 2,104 shares. The insider’s holdings dropped to 20,647 shares worth approximately $2.28 million following the completion of this transaction.
Also, Espinoza Octavio purchased 2,104 shares, netting a total of over 244,851 in proceeds.
Before that, LAMATTINA JOHN L had sold 2,406 shares from its account. In a trade valued at $297,502, the Director traded Ligand Pharmaceuticals, Inc shares for $123.65 each. Upon closing the transaction, the insider’s holdings decreased to 2,406 shares, worth approximately $3.26 million.
As published in their initiating research note from Oppenheimer on October 03, 2024, Ligand Pharmaceuticals, Inc [LGND] has been an Outperform and the price target has been revised to $135. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in late July. Earlier on February 04, 2021, H.C. Wainwright resumed its rating. Their recommendation was “a Buy” for LGND stock.
Analyzing LGND Stock Performance
During the last five days, there has been a surge of approximately 3.20%. Over the course of the year, Ligand Pharmaceuticals, Inc shares have jumped approximately 3.20%. Shares of the company reached a 52-week high of $112.61 on 01/06/25 and a 52-week low of $105.89 on 01/02/25. A 50-day SMA is recorded $115.84, while a 200-day SMA reached $97.60. Nevertheless, trading volume fell to 67142.0 shares from 94500.0 shares the previous day.
Support And Resistance Levels for Ligand Pharmaceuticals, Inc (LGND)
According to the 24-hour chart, there is a support level at 108.43, which, if violated, would cause prices to drop to 106.28. In the upper region, resistance lies at 111.82. The next price resistance is at 113.06. RSI (Relative Strength Index) is 45.76 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.42, which suggests the price will decrease in the coming days. Percent R is at 65.79%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
